Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses.

Markowitz LE, Naleway AL, Klein NP, Lewis RM, Crane B, Querec TD, Hsiao A, Aukes L, Timbol J, Weinmann S, Liu G, Steinau M, Unger ER.

J Infect Dis. 2019 Nov 30. pii: jiz555. doi: 10.1093/infdis/jiz555. [Epub ahead of print]

PMID:
31784749
2.

Transgender Women Have Higher Human Papillomavirus Prevalence Than Men Who Have Sex With Men-Two U.S. Cities, 2012-2014.

Singh V, Gratzer B, Gorbach PM, Crosby RA, Panicker G, Steinau M, Amiling R, Unger ER, Markowitz LE, Meites E.

Sex Transm Dis. 2019 Oct;46(10):657-662. doi: 10.1097/OLQ.0000000000001051.

PMID:
31517805
3.

Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination.

Markowitz LE, Naleway AL, Lewis RM, Crane B, Querec TD, Weinmann S, Steinau M, Unger ER.

Vaccine. 2019 Jun 27;37(29):3918-3924. doi: 10.1016/j.vaccine.2019.04.099. Epub 2019 May 31.

PMID:
31160099
4.

Human papillomavirus DNA detection, p16INK4a, and oral cavity cancer in a U.S. population.

Hernandez BY, Lynch CF, Chan OTM, Goodman MT, Unger ER, Steinau M, Thompson TD, Gillison M, Lyu C, Saraiya M; HPV Typing of Cancer Workgroup.

Oral Oncol. 2019 Apr;91:92-96. doi: 10.1016/j.oraloncology.2019.03.001. Epub 2019 Mar 5.

PMID:
30926069
5.

Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio.

Reiter PL, Shoben AB, McDonough D, Ruffin MT, Steinau M, Unger ER, Paskett ED, Katz ML.

Sex Transm Dis. 2019 Mar;46(3):185-190. doi: 10.1097/OLQ.0000000000000944.

PMID:
30461597
6.

Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.

Oliver SE, Gorbach PM, Gratzer B, Steinau M, Collins T, Parrish A, Kerndt PR, Crosby RA, Unger ER, Markowitz LE, Meites E.

Sex Transm Dis. 2018 Oct;45(10):660-665. doi: 10.1097/OLQ.0000000000000845.

7.

Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era.

Oakley F, Desouki MM, Pemmaraju M, Gargano JM, Markowitz LE, Steinau M, Unger ER, Zhu Y, Fadare O, Griffin MR.

Am J Prev Med. 2018 Jul;55(1):19-25. doi: 10.1016/j.amepre.2018.03.015. Epub 2018 May 16.

PMID:
29778314
8.

Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014.

Lewis RM, Markowitz LE, Gargano JW, Steinau M, Unger ER.

J Infect Dis. 2018 Mar 5;217(6):869-877. doi: 10.1093/infdis/jix655.

9.

p16(INK4A) expression in invasive laryngeal cancer.

Hernandez BY, Rahman M, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Goodman MT, Powers A, Lyu C, Saraiya M.

Papillomavirus Res. 2016 Dec;2:52-55. doi: 10.1016/j.pvr.2016.03.001. Epub 2016 Mar 9.

10.

Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.

Oliver SE, Unger ER, Lewis R, McDaniel D, Gargano JW, Steinau M, Markowitz LE.

J Infect Dis. 2017 Sep 1;216(5):594-603. doi: 10.1093/infdis/jix244.

11.

The FER rs4957796 TT genotype is associated with unfavorable 90-day survival in Caucasian patients with severe ARDS due to pneumonia.

Hinz J, Büttner B, Kriesel F, Steinau M, Frederik Popov A, Ghadimi M, Beissbarth T, Tzvetkov M, Bergmann I, Mansur A.

Sci Rep. 2017 Aug 29;7(1):9887. doi: 10.1038/s41598-017-08540-7.

12.

Concordance Between Anal and Oral Human Papillomavirus Infections Among Young Men Who have Sex With Men.

Steinau M, Gorbach P, Gratzer B, Braxton J, Kerndt PR, Crosby RA, Unger ER, Markowitz LE, Meites E.

J Infect Dis. 2017 Jun 15;215(12):1832-1835. doi: 10.1093/infdis/jix232.

PMID:
28505338
13.

Prevalence of Genital Human Papillomavirus in Males, United States, 2013-2014.

Gargano JW, Unger ER, Liu G, Steinau M, Meites E, Dunne E, Markowitz LE.

J Infect Dis. 2017 Apr 1;215(7):1070-1079. doi: 10.1093/infdis/jix057.

PMID:
28170037
14.

Universal Human Papillomavirus Typing Assay: Whole-Genome Sequencing following Target Enrichment.

Li T, Unger ER, Batra D, Sheth M, Steinau M, Jasinski J, Jones J, Rajeevan MS.

J Clin Microbiol. 2017 Mar;55(3):811-823. doi: 10.1128/JCM.02132-16. Epub 2016 Dec 14.

15.

Prevalence of 9-Valent Human Papillomavirus Types by Race/Ethnicity in the Prevaccine Era, United States, 2003-2006.

Liu G, Unger ER, Hariri S, Steinau M, Markowitz LE.

Sex Transm Dis. 2016 Oct;43(10):633-6. doi: 10.1097/OLQ.0000000000000492.

PMID:
27631358
16.

Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014.

Meites E, Gorbach PM, Gratzer B, Panicker G, Steinau M, Collins T, Parrish A, Randel C, McGrath M, Carrasco S, Moore J, Zaidi A, Braxton J, Kerndt PR, Unger ER, Crosby RA, Markowitz LE.

J Infect Dis. 2016 Sep 1;214(5):689-96. doi: 10.1093/infdis/jiw232. Epub 2016 Jun 13.

17.

Prevalence of HPV After Introduction of the Vaccination Program in the United States.

Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER.

Pediatrics. 2016 Mar;137(3):e20151968. doi: 10.1542/peds.2015-1968. Epub 2016 Feb 22.

18.

Human papillomavirus genotype and oropharynx cancer survival in the United States of America.

Goodman MT, Saraiya M, Thompson TD, Steinau M, Hernandez BY, Lynch CF, Lyu CW, Wilkinson EJ, Tucker T, Copeland G, Peters ES, Altekruse S, Unger ER.

Eur J Cancer. 2015 Dec;51(18):2759-67. doi: 10.1016/j.ejca.2015.09.005. Epub 2015 Nov 18.

19.

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.

Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML; Hpv-Impact Working Group.

Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841.

20.

Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy.

Conley LJ, Bush TJ, Darragh TM, Palefsky JM, Unger ER, Patel P, Steinau M, Kojic EM, Martin H, Overton ET, Cu-Uvin S, Hammer J, Henry K, Wood K, Brooks JT; SUN Study Group.

J Infect Dis. 2016 Feb 1;213(3):351-60. doi: 10.1093/infdis/jiv408. Epub 2015 Aug 12.

21.

Ebola Virus Diagnostics: The US Centers for Disease Control and Prevention Laboratory in Sierra Leone, August 2014 to March 2015.

Flint M, Goodman CH, Bearden S, Blau DM, Amman BR, Basile AJ, Belser JA, Bergeron É, Bowen MD, Brault AC, Campbell S, Chakrabarti AK, Dodd KA, Erickson BR, Freeman MM, Gibbons A, Guerrero LW, Klena JD, Lash RR, Lo MK, McMullan LK, Momoh G, Massally JL, Goba A, Paddock CD, Priestley RA, Pyle M, Rayfield M, Russell BJ, Salzer JS, Sanchez AJ, Schuh AJ, Sealy TK, Steinau M, Stoddard RA, Taboy C, Turnsek M, Wang D, Zemtsova GE, Zivcec M, Spiropoulou CF, Ströher U, Towner JS, Nichol ST, Bird BH.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S350-8. doi: 10.1093/infdis/jiv361. Epub 2015 Jul 30.

PMID:
26232439
22.

Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013.

Dunne EF, Naleway A, Smith N, Crane B, Weinmann S, Braxton J, Steinau M, Unger ER, Markowitz LE.

J Infect Dis. 2015 Dec 15;212(12):1970-5. doi: 10.1093/infdis/jiv342. Epub 2015 Jun 29.

PMID:
26123561
23.

Genetic Polymorphisms in Endothelin-1 as Predictors for Long-Term Survival and the Cardiac Index in Patients Undergoing On-Pump Cardiac Surgery.

Mansur A, Steinau M, Popov AF, Milenovic S, Bireta C, Weymann A, Schotola H, Wiese CH, Beissbarth T, Tzvetkov M, Hinz J.

PLoS One. 2015 Jun 29;10(6):e0131155. doi: 10.1371/journal.pone.0131155. eCollection 2015.

24.

Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study.

Mansur A, Steinau M, Popov AF, Ghadimi M, Beissbarth T, Bauer M, Hinz J.

BMC Med. 2015 Jun 1;13:128. doi: 10.1186/s12916-015-0368-6.

25.

The CD14 rs2569190 TT Genotype Is Associated with an Improved 30-Day Survival in Patients with Sepsis: A Prospective Observational Cohort Study.

Mansur A, Liese B, Steinau M, Ghadimi M, Bergmann I, Tzvetkov M, Popov AF, Beissbarth T, Bauer M, Hinz J.

PLoS One. 2015 May 28;10(5):e0127761. doi: 10.1371/journal.pone.0127761. eCollection 2015.

26.

Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis.

Mansur A, Mulwande E, Steinau M, Bergmann I, Popov AF, Ghadimi M, Beissbarth T, Bauer M, Hinz J.

Sci Rep. 2015 May 21;5:10539. doi: 10.1038/srep10539.

27.

US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT; HPV Typing of Cancers Workgroup.

J Natl Cancer Inst. 2015 Apr 29;107(6):djv086. doi: 10.1093/jnci/djv086. Print 2015 Jun.

28.

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.

Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW, Abdullah N, Levine D, Johnson ML, Steinau M, Markowitz LE; HPV-IMPACT Working Group.

Vaccine. 2015 Mar 24;33(13):1608-13. doi: 10.1016/j.vaccine.2015.01.084. Epub 2015 Feb 11.

PMID:
25681664
29.

Human papillomavirus prevalence in invasive laryngeal cancer in the United States.

Hernandez BY, Goodman MT, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Lyu C, Saraiya M; HPV Typing of Cancer Workgroup.

PLoS One. 2014 Dec 29;9(12):e115931. doi: 10.1371/journal.pone.0115931. eCollection 2014.

30.

HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States.

Hariri S, Unger ER, Schafer S, Niccolai LM, Park IU, Bloch KC, Bennett NM, Steinau M, Johnson ML, Markowitz LE; HPV-IMPACT Working Group.

Cancer Epidemiol Biomarkers Prev. 2015 Feb;24(2):393-9. doi: 10.1158/1055-9965.EPI-14-0649. Epub 2014 Nov 21.

31.

The regulatory toll-like receptor 4 genetic polymorphism rs11536889 is associated with renal, coagulation and hepatic organ failure in sepsis patients.

Mansur A, von Gruben L, Popov AF, Steinau M, Bergmann I, Ross D, Ghadimi M, Beissbarth T, Bauer M, Hinz J.

J Transl Med. 2014 Jun 21;12:177. doi: 10.1186/1479-5876-12-177.

32.

Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.

Saraiya M, Benard VB, Greek AA, Steinau M, Patel S, Massad LS, Sawaya GF, Unger ER.

Am J Obstet Gynecol. 2014 Oct;211(4):354.e1-6. doi: 10.1016/j.ajog.2014.05.001. Epub 2014 May 6.

33.

Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population.

Sinno AK, Saraiya M, Thompson TD, Hernandez BY, Goodman MT, Steinau M, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Watson M, Lyu C, Unger ER.

Obstet Gynecol. 2014 Apr;123(4):817-21. doi: 10.1097/AOG.0000000000000171.

34.

Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States.

Steinau M, Saraiya M, Goodman MT, Peters ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY, Copeland G, Saber MS, Hopenhayn C, Huang Y, Cozen W, Lyu C, Unger ER; HPV Typing of Cancers Workgroup.

Emerg Infect Dis. 2014 May;20(5):822-8. doi: 10.3201/eid2005.131311.

35.

Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population.

Hernandez BY, Goodman MT, Unger ER, Steinau M, Powers A, Lynch CF, Cozen W, Saber MS, Peters ES, Wilkinson EJ, Copeland G, Hopenhayn C, Huang Y, Watson M, Altekruse SF, Lyu C, Saraiya M; HPV Typing of Cancer Workgroup.

Front Oncol. 2014 Feb 5;4:9. doi: 10.3389/fonc.2014.00009. eCollection 2014.

36.

Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction.

Hopenhayn C, Christian A, Christian WJ, Watson M, Unger ER, Lynch CF, Peters ES, Wilkinson EJ, Huang Y, Copeland G, Cozen W, Saber MS, Goodman MT, Hernandez BY, Steinau M, Lyu C, Tucker TT, Saraiya M.

J Low Genit Tract Dis. 2014 Apr;18(2):182-9. doi: 10.1097/LGT.0b013e3182a577c7.

37.

Reply to Groner et al and Pei et al.

Markowitz LE, Hariri S, Dunne EF, Steinau M, Unger ER.

J Infect Dis. 2014 Apr 15;209(8):1304-5. doi: 10.1093/infdis/jit835. Epub 2013 Dec 23. No abstract available.

PMID:
24368839
38.

Prevalence of cervical and oral human papillomavirus infections among US women.

Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, Markowitz LE, Unger ER.

J Infect Dis. 2014 Jun 1;209(11):1739-43. doi: 10.1093/infdis/jit799. Epub 2013 Dec 5.

39.

Urine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women.

Mendez K, Romaguera J, Ortiz AP, López M, Steinau M, Unger ER.

Int J Gynaecol Obstet. 2014 Feb;124(2):151-5. doi: 10.1016/j.ijgo.2013.07.036. Epub 2013 Nov 1.

40.

HPV genotypes detected in cervical cancers from Alaska Native women, 1980-2007.

Kelly JJ, Unger ER, Dunne EF, Murphy NJ, Tiesinga J, Koller KR, Swango-Wilson A, Philemonof D, Lounmala X, Markowitz LE, Steinau M, Hennessy T.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21115. eCollection 2013.

41.

Evaluation of genital self-sampling methods for HPV detection in males.

Hernandez BY, Wilkens LR, Unger ER, Steinau M, Markowitz L, Garvin K, Thompson PJ, Shvetsov YB, O'Dillon K, Dunne EF.

J Clin Virol. 2013 Sep;58(1):168-75. doi: 10.1016/j.jcv.2013.06.032. Epub 2013 Jul 20.

PMID:
23880161
42.

Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.

Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER.

J Infect Dis. 2013 Aug 1;208(3):385-93. doi: 10.1093/infdis/jit192. Epub 2013 Jun 19.

PMID:
23785124
43.

Genital human papillomaviruses among women of reproductive age in Jamaica.

Lewis-Bell K, Luciani S, Unger ER, Hariri S, McFarlane S, Steinau M, Prieto-Lara E, Vicari AS, Irons B, Lewis MJ, Andrus JK.

Rev Panam Salud Publica. 2013 Mar;33(3):159-65.

PMID:
23698134
44.

Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction.

Steinau M, Unger ER, Hernandez BY, Goodman MT, Copeland G, Hopenhayn C, Cozen W, Saber MS, Huang Y, Peters ES, Lynch CF, Wilkinson EJ, Rajeevan MS, Lyu C, Saraiya M.

J Low Genit Tract Dis. 2013 Oct;17(4):397-403. doi: 10.1097/LGT.0b013e31827ed372.

45.

Can clinical tests help monitor human papillomavirus vaccine impact?

Meites E, Lin C, Unger ER, Steinau M, Patel S, Markowitz LE, Hariri S.

Int J Cancer. 2013 Sep 1;133(5):1101-6. doi: 10.1002/ijc.28115. Epub 2013 Mar 13.

46.

Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact.

Dunne EF, Klein NP, Naleway AL, Baxter R, Weinmann S, Riedlinger K, Fetterman B, Steinau M, Scarbrough MZ, Gee J, Markowitz LE, Unger ER.

Cancer Causes Control. 2013 Feb;24(2):403-7. doi: 10.1007/s10552-012-0085-9. Epub 2013 Jan 5.

PMID:
23292130
47.

Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions.

Powell SE, Hariri S, Steinau M, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Unger ER, Markowitz LE.

Vaccine. 2012 Dec 17;31(1):109-13. doi: 10.1016/j.vaccine.2012.10.092. Epub 2012 Nov 6.

PMID:
23137842
48.

Human papillomavirus genotypes in high-grade cervical lesions in the United States.

Hariri S, Unger ER, Powell SE, Bauer HM, Bennett NM, Bloch KC, Niccolai LM, Schafer S, Steinau M, Markowitz LE; HPV-IMPACT Working Group.

J Infect Dis. 2012 Dec 15;206(12):1878-86. doi: 10.1093/infdis/jis627. Epub 2012 Oct 8.

PMID:
23045628
49.

Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction.

Gargano JW, Wilkinson EJ, Unger ER, Steinau M, Watson M, Huang Y, Copeland G, Cozen W, Goodman MT, Hopenhayn C, Lynch CF, Hernandez BY, Peters ES, Saber MS, Lyu CW, Sands LA, Saraiya M.

J Low Genit Tract Dis. 2012 Oct;16(4):471-9. doi: 10.1097/LGT.0b013e3182472947.

50.

HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.

Hariri S, Steinau M, Rinas A, Gargano JW, Ludema C, Unger ER, Carter AL, Grant KL, Bamberg M, McDermott JE, Markowitz LE, Brewer NT, Smith JS.

PLoS One. 2012;7(3):e34044. doi: 10.1371/journal.pone.0034044. Epub 2012 Mar 29.

Supplemental Content

Loading ...
Support Center